首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   94168篇
  免费   9025篇
  国内免费   2105篇
耳鼻咽喉   761篇
儿科学   1471篇
妇产科学   1189篇
基础医学   6368篇
口腔科学   2157篇
临床医学   14679篇
内科学   11781篇
皮肤病学   988篇
神经病学   5080篇
特种医学   2699篇
外国民族医学   6篇
外科学   8049篇
综合类   11779篇
现状与发展   5篇
一般理论   4篇
预防医学   18138篇
眼科学   1208篇
药学   8234篇
  267篇
中国医学   5797篇
肿瘤学   4638篇
  2024年   427篇
  2023年   2012篇
  2022年   3288篇
  2021年   4662篇
  2020年   5001篇
  2019年   3926篇
  2018年   3641篇
  2017年   4047篇
  2016年   3894篇
  2015年   3795篇
  2014年   7184篇
  2013年   7463篇
  2012年   6134篇
  2011年   6303篇
  2010年   4897篇
  2009年   4831篇
  2008年   4771篇
  2007年   4396篇
  2006年   3945篇
  2005年   3224篇
  2004年   2651篇
  2003年   2314篇
  2002年   1886篇
  2001年   1546篇
  2000年   1179篇
  1999年   985篇
  1998年   787篇
  1997年   748篇
  1996年   622篇
  1995年   599篇
  1994年   473篇
  1993年   410篇
  1992年   376篇
  1991年   296篇
  1990年   305篇
  1989年   265篇
  1988年   255篇
  1987年   225篇
  1986年   203篇
  1985年   241篇
  1984年   203篇
  1983年   135篇
  1982年   149篇
  1981年   125篇
  1980年   119篇
  1979年   72篇
  1978年   57篇
  1977年   38篇
  1976年   56篇
  1975年   31篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
72.
高强度超声对犬前列腺组织损伤的实验研究   总被引:1,自引:0,他引:1  
目的 探讨经尿道高强度超声 (transurethralhighintensityultrasound ,TUHIU)治疗良性前列腺增生症 (benignprostatichyperplasia ,BPH)的有效性和可行性。方法 对犬前列腺进行TUHIU辐照处理 ,辐照后不同时期处死动物以观察其急性、亚急性和慢性期大体及组织病理变化。同时观察辐照前后影像学变化。结果 TUHIU辐照前前列腺部尿道平均最大宽度为 0 66± 0 12 ( x±s)cm ,辐照 3周后前列腺部尿道平均最大宽度为 2 11± 1 0 7cm ,较辐照前显著增宽。辐照后可见靶区内尿道周围腺体发生凝固性坏死 ,3 0~ 60天后坏死组织脱落尿道呈囊腔状。光、电镜下均可见腺上皮及基质细胞发生均匀性凝固性坏死。辐照后经腹B超示前列腺内部出现液性暗区 ,前列腺呈囊性改变。辐照后即刻各犬均出现短暂性尿潴留、尿频、尿线变细 ,1月后恢复正常。结论 TUHIU可破坏前列腺组织 ,明显增加前列腺部尿道宽度。  相似文献   
73.
Ciclesonide is an onsite-activated inhaled corticosteroid (ICS) for the treatment of asthma. This study compared the efficacy, safety and effect on quality of life (QOL) of ciclesonide 160 microg (ex-actuator; nominal dose 200 microg) vs. budesonide 400 microg (nominal dose) in children with asthma. Six hundred and twenty-one children (aged 6-11 yr) with asthma were randomized to receive ciclesonide 160 microg (ex-actuator) once daily (via hydrofluoroalkane metered-dose inhaler and AeroChamber Plus spacer) or budesonide 400 microg once daily (via Turbohaler) both given in the evening for 12 wk. The primary efficacy end-point was change in forced expiratory volume in 1 s (FEV1). Additional measurements included change in daily peak expiratory flow (PEF), change in asthma symptom score sum, change in use of rescue medication, paediatric and caregiver asthma QOL questionnaire [PAQLQ(S) and PACQLQ, respectively] scores, change in body height assessed by stadiometry, change in 24-h urinary cortisol adjusted for creatinine and adverse events. Both ciclesonide and budesonide increased FEV1, morning PEF and PAQLQ(S) and PACQLQ scores, and improved asthma symptom score sums and the need for rescue medication after 12 wk vs. baseline. The non-inferiority of ciclesonide vs. budesonide was demonstrated for the change in FEV1 (95% confidence interval: -75, 10 ml, p = 0.0009, one-sided non-inferiority, per-protocol). In addition, ciclesonide and budesonide showed similar efficacy in improving asthma symptoms, morning PEF, use of rescue medication and QOL. Ciclesonide was superior to budesonide with regard to increases in body height (p = 0.003, two-sided). The effect on the hypothalamic-pituitary-adrenal axis was significantly different in favor of ciclesonide treatment (p < 0.001, one-sided). Both ciclesonide and budesonide were well tolerated. Ciclesonide 160 microg once daily and budesonide 400 microg once daily were effective in children with asthma. In addition, in children treated with ciclesonide there was significantly less reduction in body height and suppression of 24-h urinary cortisol excretion compared with children treated with budesonide after 12 wk.  相似文献   
74.
Objectives: The authors reviewed the evidence on performance improvement methods for increasing emergency department (ED) patient satisfaction to provide evidence-based suggestions for clinical practice.
Methods: Data sources consisted of searches through MEDLINE, CINAHL, PSYCHINFO, Cochrane Library, and Emergency Medicine Abstracts and a manual search of references. Articles were included if they reported a performance improvement intervention targeting patient satisfaction in the ED setting. Articles on studies not conducted in the United States or that failed to provide enough details to allow critical evaluation of the study were excluded. Two authors used structured evaluation criteria to independently review each retained study.
Results: Nineteen articles met all selection criteria. Three studies found varying levels of support for multicomponent interventions, predominantly focused on implementation of clinical practice guidelines for specific presenting complaints and process redesign. Sixteen studies evaluated single-component interventions, with the following having at least one supportive study: using alternating patient assignment to provider teams rather than "zone"-based assignment, enhancing provider communication and customer service skills, incorporating information delivery interventions (e.g., pamphlets, video) that target patient expectations, using preformatted charts, and establishing ED-based observation units for specific conditions such as asthma and chest pain.
Conclusions: There is modest evidence supporting a range of performance improvement interventions for improving ED patient satisfaction. Further work is needed before specific, evidence-based recommendations can be made regarding which process changes are most effective. Recommendations are made for improving the quality of performance improvement efforts in the ED setting.  相似文献   
75.
Subjects with central field loss (CFL) individually selected enhancement parameters to improve visibility of static video images. The effect of enhancement on performance and on perceived quality of motion video was assessed. Performance, e.g. recognition of visual details, was assessed by having subjects answer questions regarding visual information contained in the video motion segments that were enhanced using the individually-selected parameters. Enhancement did not improve subject performance on questions about video content. This result might be due to a ceiling effect limitation of the performance assessment method. In a second procedure, subjects' continuous perceptions of quality (using an adjective-based rating scale) were made while the enhancement parameters were abruptly switched among multiple values; these included the individually-selected enhancements, as well as unenhanced, over-enhanced, and degraded segments. The results indicate that adaptive enhancement (individually-tuned using a static image) adds significantly to perceived image quality when viewing motion video. Subjects who selected stronger contrast enhancement also perceived the enhancement to provide a larger benefit in image quality.  相似文献   
76.
77.
传染病流行的社会因素及社会控制策略刍议   总被引:4,自引:3,他引:1  
传染病与社会文化因素的关系密切。应重视社会因素对传染病的发生发展影响,从社会根源上探究其发病原理,包括经济因素、科学技术、文化、人口、卫生服务和其它社会因素。人类要有与传染病长期斗争的思想准备,并制定包括大卫生观和技术合作等相应的社会策略。  相似文献   
78.
Aim This paper seeks to illumine how families with children and adult members with intellectual disabilities manage to manifest a buoyant and durable capacity over time. It is therefore concerned centrally with the idea of resilience. Method Drawing from diverse theoretical literatures from child development and protection and gerontology, the paper begins with a review of constructions of resilience. In an attempt to assess where there seems to be support for resilience in families, the core of the paper tests empirical evidence about positive experiences of families supporting children and adults with intellectual disabilities against the theoretical literature on resilience. Result and Conclusions The findings are used to suggest conditions under which resilience is produced and maintained, and to identify emergent elements of a psycho‐social model of resilience in families with children and adult members with intellectual disabilities.  相似文献   
79.
Background Health-related quality of life (HRQL) is an accepted outcome measure in patients with mood and anxiety disorders. Yet, surprisingly little attention has been paid to the determinants. In this paper we test the hypothesis that it is associated with personality traits while controlling for mental disorders. Methods A large sample of outpatients (n=640) with mood and anxiety disorders was studied. The empirically supported five factor model of normal personality traits was assessed using the NEO-FFI and includes: neuroticism, extraversion, openness to experience, agreeableness, and conscientiousness. Mental disorders were assessed with the CIDI, and HRQL with the SF-36. Results Regression analyses revealed that the NEO-FFI scores, with the exception of conscientiousness, were significantly associated with SF-36 subscales and summary scores, independently from the mental disorders. The percentage of explained variance due to the personality traits was highest for the subscales Vitality (10.0%), Mental Health (13.3%) and the Mental Health Summary Score (9.5%). Furthermore, specific personality traits were related to specific SF-36 subscales. Conclusions A low HRQL of patients with mood or anxiety disorders is not only determined by the disease or the current health but is also shaped by personality traits that are relatively stable throughout an individual's life time.  相似文献   
80.
病案作为记录医疗活动过程的重要载体,包含着各类丰富的信息。医疗服务质量评价有很多内容是通过病案实现的。作者分析了包括"三级医师查房"在内的20余项在病案中反映的医疗服务质量项目,指出影响质量判断的常见因素,并提出解决的对策与措施。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号